HIGHLIGHTS
- who: Gauthier Kielwasser et al. from the , Lyon, France have published the research work: Real-Life Value of the Odysight® Application in At-Home Screening for Exudative Recurrence of Macular Edema, in the Journal: (JOURNAL)
- how: The authors conducted an observational multicenter retrospective study.
SUMMARY
Of 10 3 of 10 If the decrease of >5 VA letters is confirmed, then the alert is triggered. The primary endpoint was the Sensitivity (Se) of alerts generated by the application; Se was the probability of an alert when the patient had macular edema recurrence . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.